UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2009
AmerisourceBergen Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-16671
|
|
23-3079390 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
|
|
|
1300 Morris Drive
Chesterbrook, PA
|
|
19087 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code: (610) 727-7000
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01. Entry into a Material Definitive Agreement.
For purposes hereof, the Registrant means AmerisourceBergen Corporation.
On April 30, 2009, the Ninth Amendment (the Ninth Amendment) to the Registrants accounts
receivables securitization facility (now with a base size of $700 million) became effective. The
securitization facility was originally entered into as of July 10, 2003 among Amerisource
Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as initial
servicer, various financial institutions, as purchasers, and the administrator, and has been
subsequently amended. Bank of America, National Association, is currently the administrator under
the Registrants securitization facility.
The Ninth Amendment extends the maturity date of the securitization facility and the
Registrant chose to reduce the base size of the securitization facility from $975 million to $700
million. The securitization facility retains an accordion feature, which permits commitments under
the facility to increase, subject to lender approval, to $950 million for seasonal needs during the
December and March quarter. The securitization facility will expire on April 29, 2010. The
average cost of the securitization facility was increased in connection with the Ninth Amendment
due to current market conditions.
A copy of the Ninth Amendment is filed as Exhibit 99.1 to this report and is incorporated
herein by reference.
Item 2.03. Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.
The information set forth in Item 1.01 above is hereby incorporated by reference under this
Item 2.03.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 The Ninth Amendment to Receivables Purchase Agreement, dated as of April 30, 2009, among
Amerisource Receivables Financial Corporation, as Seller, AmerisourceBergen Drug Corporation, as
initial Servicer, the Purchaser Agents and Purchasers, the Exiting Purchaser Groups and Bank of
America, National Association, as Administrator.